|
2023-03-10 |
2023-03-10 |
A
Achat
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
51 599 200
+889.5%
27,00
1 393 178 400
USD
|
51 599 200
+889.5%
|
27,00
|
1 393 178 400
USD
|
|
|
2023-01-20 |
2023-01-18 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 109
-0.4%
26,89
29 821
USD
|
1 109
-0.4%
|
26,89
|
29 821
USD
|
|
|
2023-01-20 |
2023-01-18 |
V
Vente
|
Merendino Lauren
Chief Commercial Officer
Dirigeant
|
2 008
-1.2%
26,89
53 995
USD
|
2 008
-1.2%
|
26,89
|
53 995
USD
|
|
|
2023-01-20 |
2023-01-18 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
1 272
-0.4%
26,89
34 204
USD
|
1 272
-0.4%
|
26,89
|
34 204
USD
|
|
|
2023-01-20 |
2023-01-18 |
V
Vente
|
Marek David C
Principal Executive Officer
Administrateur exécutif
|
8 037
-1.9%
26,89
216 115
USD
|
8 037
-1.9%
|
26,89
|
216 115
USD
|
|
|
2023-01-05 |
2023-01-04 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
2 251
-0.9%
26,90
60 552
USD
|
2 251
-0.9%
|
26,90
|
60 552
USD
|
|
|
2023-01-05 |
2023-01-04 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
2 779
-0.8%
26,90
74 755
USD
|
2 779
-0.8%
|
26,90
|
74 755
USD
|
|
|
2022-12-20 |
2022-12-16 |
V
Vente
|
Mehra Uneek
Principal Financial Officer
Dirigeant
|
2 241
-1.1%
26,75
59 947
USD
|
2 241
-1.1%
|
26,75
|
59 947
USD
|
|
|
2022-10-20 |
2022-10-18 |
V
Vente
|
Marek David C
Principal Executive Officer
Administrateur exécutif
|
11 156
-2.6%
25,20
281 131
USD
|
11 156
-2.6%
|
25,20
|
281 131
USD
|
|
|
2022-10-20 |
2022-10-18 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 604
-0.6%
25,20
40 421
USD
|
1 604
-0.6%
|
25,20
|
40 421
USD
|
|
|
2022-10-20 |
2022-10-18 |
V
Vente
|
Merendino Lauren
Chief Commercial Officer
Dirigeant
|
1 703
-1.0%
25,20
42 916
USD
|
1 703
-1.0%
|
25,20
|
42 916
USD
|
|
|
2022-10-20 |
2022-10-18 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
1 933
-0.5%
25,20
48 712
USD
|
1 933
-0.5%
|
25,20
|
48 712
USD
|
|
|
2022-10-06 |
2022-10-04 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
3 679
-1.0%
24,40
89 768
USD
|
3 679
-1.0%
|
24,40
|
89 768
USD
|
|
|
2022-10-06 |
2022-10-04 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
2 738
-1.1%
24,40
66 807
USD
|
2 738
-1.1%
|
24,40
|
66 807
USD
|
|
|
2022-09-20 |
2022-09-16 |
V
Vente
|
Mehra Uneek
Principal Financial Officer
Dirigeant
|
9 243
-4.3%
18,86
174 323
USD
|
9 243
-4.3%
|
18,86
|
174 323
USD
|
|
|
2022-08-16 |
2022-08-15 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
31 214
-7.9%
18,23
569 031
USD
|
31 214
-7.9%
|
18,23
|
569 031
USD
|
|
|
2022-07-20 |
2022-07-18 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 606
-0.6%
12,87
20 669
USD
|
1 606
-0.6%
|
12,87
|
20 669
USD
|
|
|
2022-07-20 |
2022-07-18 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
1 935
-0.7%
12,87
24 903
USD
|
1 935
-0.7%
|
12,87
|
24 903
USD
|
|
|
2022-07-20 |
2022-07-18 |
V
Vente
|
Merendino Lauren
Chief Commercial Officer
Dirigeant
|
1 704
-1.0%
12,87
21 930
USD
|
1 704
-1.0%
|
12,87
|
21 930
USD
|
|
|
2022-07-20 |
2022-07-18 |
V
Vente
|
Marek David C
Principal Executive Officer
Administrateur exécutif
|
11 164
-2.5%
12,87
143 681
USD
|
11 164
-2.5%
|
12,87
|
143 681
USD
|
|
|
2022-07-08 |
2022-07-06 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
2 755
-1.1%
13,40
36 917
USD
|
2 755
-1.1%
|
13,40
|
36 917
USD
|
|
|
2022-07-08 |
2022-07-06 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
3 702
-1.3%
13,40
49 607
USD
|
3 702
-1.3%
|
13,40
|
49 607
USD
|
|
|
2022-06-01 |
2022-05-27 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 382
-0.5%
10,07
13 917
USD
|
1 382
-0.5%
|
10,07
|
13 917
USD
|
|
|
2022-04-21 |
2022-04-19 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
4 632
-1.7%
10,45
48 404
USD
|
4 632
-1.7%
|
10,45
|
48 404
USD
|
|
|
2022-04-21 |
2022-04-19 |
V
Vente
|
Merendino Lauren
Chief Commercial Officer
Dirigeant
|
7 049
-3.9%
10,45
73 662
USD
|
7 049
-3.9%
|
10,45
|
73 662
USD
|
|
|
2022-04-21 |
2022-04-19 |
V
Vente
|
Marek David C
Principal Executive Officer
Administrateur exécutif
|
24 594
-5.2%
10,45
257 007
USD
|
24 594
-5.2%
|
10,45
|
257 007
USD
|
|
|
2022-04-21 |
2022-04-19 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
8 002
-2.8%
10,45
83 621
USD
|
8 002
-2.8%
|
10,45
|
83 621
USD
|
|
|
2022-04-07 |
2022-04-05 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 922
-1.2%
13,78
26 485
USD
|
1 922
-1.2%
|
13,78
|
26 485
USD
|
|
|
2022-04-07 |
2022-04-05 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
2 436
-1.4%
13,78
33 568
USD
|
2 436
-1.4%
|
13,78
|
33 568
USD
|
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 362
-0.8%
13,35
18 183
USD
|
1 362
-0.8%
|
13,35
|
18 183
USD
|
|
|
2022-01-21 |
2022-01-19 |
V
Vente
|
Marek David C
Principal Executive Officer
Administrateur exécutif
|
19 882
-5.6%
14,68
291 868
USD
|
19 882
-5.6%
|
14,68
|
291 868
USD
|
|
|
2022-01-06 |
2022-01-04 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
2 271
-1.4%
16,27
36 949
USD
|
2 271
-1.4%
|
16,27
|
36 949
USD
|
|
|
2022-01-06 |
2022-01-04 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
4 475
-2.5%
16,27
72 808
USD
|
4 475
-2.5%
|
16,27
|
72 808
USD
|
|
|
2021-12-01 |
2021-11-29 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 978
-1.2%
19,30
38 175
USD
|
1 978
-1.2%
|
19,30
|
38 175
USD
|
|
|
2021-11-05 |
2021-11-04 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
3 100
-1.8%
24,02
74 462
USD
|
3 100
-1.8%
|
24,02
|
74 462
USD
|
|
|
2021-11-05 |
2021-11-03 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
700
-0.4%
24,00
16 800
USD
|
700
-0.4%
|
24,00
|
16 800
USD
|
|
|
2021-10-07 |
2021-10-05 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
2 738
-1.6%
21,62
59 196
USD
|
2 738
-1.6%
|
21,62
|
59 196
USD
|
|
|
2021-10-07 |
2021-10-05 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
6 671
-3.6%
21,62
144 227
USD
|
6 671
-3.6%
|
21,62
|
144 227
USD
|
|
|
2021-09-29 |
2021-09-27 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
7 000
-3.9%
24,32
170 240
USD
|
7 000
-3.9%
|
24,32
|
170 240
USD
|
|
|
2021-09-28 |
2021-09-27 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
2 232
+0.0%
24,86
55 486
USD
|
2 232
+0.0%
|
24,86
|
55 486
USD
|
|
|
2021-09-28 |
2021-09-27 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
45 768
+0.1%
24,19
1 106 904
USD
|
45 768
+0.1%
|
24,19
|
1 106 904
USD
|
|
|
2021-09-28 |
2021-09-24 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
36 000
+0.1%
23,40
842 548
USD
|
36 000
+0.1%
|
23,40
|
842 548
USD
|
|
|
2021-09-14 |
2021-09-13 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
30 028
+0.1%
23,91
717 990
USD
|
30 028
+0.1%
|
23,91
|
717 990
USD
|
|
|
2021-09-14 |
2021-09-13 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
53 150
+0.1%
23,09
1 227 058
USD
|
53 150
+0.1%
|
23,09
|
1 227 058
USD
|
|
|
2021-09-14 |
2021-09-10 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
30 000
+0.1%
25,11
753 390
USD
|
30 000
+0.1%
|
25,11
|
753 390
USD
|
|
|
2021-09-13 |
2021-09-09 |
VP
Vente planifiée
|
Curran Terrie
Administrateur non-exécutif
|
4 850
-100.0%
25,58
124 063
USD
|
4 850
-100.0%
|
25,58
|
124 063
USD
|
|
|
2021-09-01 |
2021-08-31 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
39 000
+0.1%
24,28
946 885
USD
|
39 000
+0.1%
|
24,28
|
946 885
USD
|
|
|
2021-09-01 |
2021-08-30 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
70 000
+0.1%
23,92
1 674 099
USD
|
70 000
+0.1%
|
23,92
|
1 674 099
USD
|
|
|
2021-08-30 |
2021-08-27 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
37 038
+0.1%
23,17
858 252
USD
|
37 038
+0.1%
|
23,17
|
858 252
USD
|
|
|
2021-08-30 |
2021-08-26 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
40 000
+0.1%
22,67
906 912
USD
|
40 000
+0.1%
|
22,67
|
906 912
USD
|
|
|
2021-08-20 |
2021-08-19 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
46 792
+0.1%
21,51
1 006 421
USD
|
46 792
+0.1%
|
21,51
|
1 006 421
USD
|
|
|
2021-08-20 |
2021-08-18 |
AP
Achat planifié
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
17 116
+0.0%
21,45
367 092
USD
|
17 116
+0.0%
|
21,45
|
367 092
USD
|
|
|
2021-06-02 |
2021-05-28 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 783
-1.0%
24,00
42 792
USD
|
1 783
-1.0%
|
24,00
|
42 792
USD
|
|
|
2021-06-02 |
2021-05-28 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 300
-0.7%
24,00
31 200
USD
|
1 300
-0.7%
|
24,00
|
31 200
USD
|
|
|
2021-05-28 |
2021-05-26 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
12 700
-6.7%
24,23
307 721
USD
|
12 700
-6.7%
|
24,23
|
307 721
USD
|
|
|
2021-04-08 |
2021-04-06 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
8 114
-6.0%
18,63
151 164
USD
|
8 114
-6.0%
|
18,63
|
151 164
USD
|
|
|
2021-04-08 |
2021-04-06 |
V
Vente
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
10 862
-7.4%
18,62
202 250
USD
|
10 862
-7.4%
|
18,62
|
202 250
USD
|
|
|
2021-03-23 |
2021-03-19 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
7 000
-4.9%
24,17
169 190
USD
|
7 000
-4.9%
|
24,17
|
169 190
USD
|
|
|
2021-03-17 |
2021-03-15 |
VP
Vente planifiée
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
30 000
-17.1%
25,07
752 013
USD
|
30 000
-17.1%
|
25,07
|
752 013
USD
|
|
|
2021-03-03 |
2021-03-01 |
V
Vente
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
1 513
-1.1%
22,55
34 118
USD
|
1 513
-1.1%
|
22,55
|
34 118
USD
|
|
|
2021-02-18 |
2021-02-16 |
VP
Vente planifiée
|
KARBE FRANK
Principal Fin'l & Accounting
Dirigeant
|
750
-0.5%
21,40
16 050
USD
|
750
-0.5%
|
21,40
|
16 050
USD
|
|
|
2021-02-01 |
2021-01-28 |
VP
Vente planifiée
|
KARBE FRANK
Principal Fin'l & Accounting
Dirigeant
|
300
-0.2%
24,00
7 200
USD
|
300
-0.2%
|
24,00
|
7 200
USD
|
|
|
2021-01-20 |
2021-01-15 |
VP
Vente planifiée
|
KARBE FRANK
Principal Fin'l & Accounting
Dirigeant
|
750
-0.5%
21,50
16 125
USD
|
750
-0.5%
|
21,50
|
16 125
USD
|
|
|
2020-12-30 |
2020-12-28 |
VP
Vente planifiée
|
KARBE FRANK
Principal Fin'l & Accounting
Dirigeant
|
11 800
-6.7%
30,00
354 000
USD
|
11 800
-6.7%
|
30,00
|
354 000
USD
|
|
|
2020-12-22 |
2020-12-18 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
2 000
-1.4%
26,00
52 000
USD
|
2 000
-1.4%
|
26,00
|
52 000
USD
|
|
|
2020-12-22 |
2020-12-18 |
VP
Vente planifiée
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
300
-0.2%
26,24
7 871
USD
|
300
-0.2%
|
26,24
|
7 871
USD
|
|
|
2020-12-22 |
2020-12-18 |
VP
Vente planifiée
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
9 700
-6.2%
25,38
246 183
USD
|
9 700
-6.2%
|
25,38
|
246 183
USD
|
|
|
2020-12-17 |
2020-12-15 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
3 467
-2.5%
24,18
83 837
USD
|
3 467
-2.5%
|
24,18
|
83 837
USD
|
|
|
2020-12-17 |
2020-12-15 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
3 533
-2.5%
23,66
83 589
USD
|
3 533
-2.5%
|
23,66
|
83 589
USD
|
|
|
2020-12-17 |
2020-12-15 |
VP
Vente planifiée
|
KARBE FRANK
Principal Fin'l & Accounting
Dirigeant
|
670
-0.4%
24,45
16 383
USD
|
670
-0.4%
|
24,45
|
16 383
USD
|
|
|
2020-12-17 |
2020-12-15 |
VP
Vente planifiée
|
KARBE FRANK
Principal Fin'l & Accounting
Dirigeant
|
380
-0.2%
23,63
8 980
USD
|
380
-0.2%
|
23,63
|
8 980
USD
|
|
|
2020-12-14 |
2020-12-10 |
VP
Vente planifiée
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Dirigeant
|
10 000
-6.8%
26,04
260 362
USD
|
10 000
-6.8%
|
26,04
|
260 362
USD
|
|
|
2020-12-11 |
2020-12-10 |
VP
Vente planifiée
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
19 400
-11.7%
25,20
488 783
USD
|
19 400
-11.7%
|
25,20
|
488 783
USD
|
|
|
2020-12-11 |
2020-12-09 |
VP
Vente planifiée
|
Lang Matthew
General Counsel & Corp. Secy.
Dirigeant
|
600
-0.4%
25,08
15 049
USD
|
600
-0.4%
|
25,08
|
15 049
USD
|
|
|
2020-12-02 |
2020-11-30 |
VP
Vente planifiée
|
KARBE FRANK
Principal Fin'l & Accounting
Dirigeant
|
1 500
-0.9%
24,00
36 000
USD
|
1 500
-0.9%
|
24,00
|
36 000
USD
|
|
